Folate Antagonists, Quinolones, and UTI Agents Flashcards
2 types of folate antagonist drugs
Sulfonamides and trimethoprim/pyrimethamine
Sulfonamides MOA
Inhibit dihydrofolate synthesis (specifically dihydropteroate synthetase)
Trimethoprim and pyrimethamine MOA
Inhibitors of folate reduction (inhibit dihydrofolate reductase)
How do humans obtain folate?
Obtain reduced folate in diet
This is an example of selective toxicity for many drugs
Sulfonamides compete with this for folate synthesis pathway
PABA (p-aminobenzoic acid)
Sulfonamides are a ______ inhibitor of nucleic acid synthesis
Indirect
Sulfonamides are a _______ inhibitor dihyropteroate synthase which prevents PABA incorporation into folic acid
Competitive
Spectrum for sulfonamides
Broad spectrum
But resistance severely limits actual clinical spectrum
4 adverse effects of sulfonamides
Crystal formation in urine
Blood problems (esp. with G6P dehydrogenase deficiency)
Hypersensitivity
Kernicterus in infants
Glucose-6-P dehydrogenase deficiency is most commonly seen in people from this descent
Mediterranean and African origin
Highest risk of acute hemolysis as a result of sulfonamide use is in patients with this
Genetic deficiency in RBC glucose-6-phosphate dehydrogenase (FAVism)
Crystal formation in urine, blood problems, hypersensitivity, and kernicterus in infants are adverse effects of this
Sulfonamides
Rare medical emergency affecting skin and mucous membranes that can be triggered by sulfonamides
Fever, malaise, erythema multiforme, ulceration of mucous membranes
Stevens-Johnson syndrome
What is Stevens-Johnson syndrome?
Rare medical emergency affecting skin and mucous membranes that can be triggered by sulfonamides
2 Adverse effects of trimethoprim and pyrimethamine
Skin rashes
Major bone marrow toxicity potential when used chronically but can be reduced with folic acid supplementation (Megaloblastic anemia, Leukopenia, Granulocytopenia)
Skin rashes and bone marrow toxicity (megaloblastic anemia, leukopenia, granulocytopenia) are adverse effects to this
Trimethoprim and Pyrimethamine
Bone marrow toxicity when trimethoprim and pyrimethamine are used chronically can be reduced with this
Folic acid supplementation
Optimal ratio for Trimethoprim-Sulfamethoxazole combination therapy
Produce sequential blockage of folate synthesis; super additive drug interaction
20 parts Sulfa to 1 part Trimethoprim
Spectrum of quinolones
Broad spectrum (block DNA synthesis and function)
Effective for gram negative rods in UTIs and GI infections, and some gram positive
MOA of quinolones
Inhibit topoisomerase II (DNA gyrase) and IV
Quinolones inhibition of this is the primary drug target in gram negative bacteria
DNA gyrase (topoisomerase II)
Quinolones inhibition of this is the primary drug target in gram positive bacteria
Topoisomerase IV
Quinolones inhibition of DNA gyrase (topoisomerase II) is the primary drug target for this type of bacteria
Gram negative
Quinolones inhibition of topoisomerase IV is the primary drug target for this type of bacteria
Gram positive
Drugs that chelates with some metals (e.g. antacids containing aluminum hydroxide or magnesium hydroxide: Maalox, Mylanta)
Quinolones
Quinolones chelates with this
Some metals
(e.g. antacids containing aluminum hydroxide or magnesium hydroxide: Maalox, Mylanta)